Probity gone nuts.

Nat Biotechnol · 2007

editorial · Level V

Where this comes from

Abstract

The thinking behind the US Food and Drug Administration's (FDA) draft guidance on financial conflicts of interest for outside experts is deeply flawed.

Medical subject headings